Browse by Audience
Skip to content
Papers of the Week
A patent review of CXCR7 modulators (2019-present).
Authors
Pillaiyar T, Laufer SAbstract
Atypical chemokine receptor 3 (ACKR3) (formerly CXCR7) regulates various biological processes through its ligands and is closely associated with numerous diseases, including inflammation, cancer, cardiovascular diseases (CVDs), pain, and neurological disorders. Therefore, ACKR3 has emerged as a potential target for disease treatment.